CoChat

The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series

Open access
Ulugut Erkoyun, Hulya, van der Lee, Sven J., Nijmeijer, Bas, van Spaendonk, Rosalina, Nelissen, Anne, Scarioni, Marta, Dijkstra, Anke, Samancı, Bedia, Gürvit, Hakan, Yıldırım, Zerrin, Tepgeç, Fatih, Bilgic, Basar, Barkhof, Frederik, Rozemuller, Annemieke, van der Flier, Wiesje M., Scheltens, Philip, Cohn-Hokke, Petra, Pijnenburg, Yolande · 2021 · Journal of Alzheimer’s Disease

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Background: Right temporal variant frontotemporal dementia (rtvFTD) has been generally considered as a right sided variant of semantic variant primary progressive aphasia (svPPA), which is a genetically sporadic disorder. Recently, we have shown that rtvFTD has a unique clinical syndrome compared to svPPA and behavioral variant frontotemporal dementia. Objective: We challenge the assumption that rtvFTD is a sporadic, non-familial variant of FTD by identifying potential autosomal dominant inheritance and related genes in rtvFTD. Methods: We collected all subjects with a diagnosis of FTD or primary progressive aphasia who had undergone genetic screening ( n = 284) and subsequently who had a genetic variant ( n = 48) with a diagnosis of rtvFTD ( n = 6) in 2 specialized memory clinics. Results: Genetic variants in FTD related genes were found in 33% of genetically screened rtvFTD cases; including MAPT ( n = 4), GRN ( n = 1), and TARDBP ( n = 1) genes, whereas only one svPPA case had a genetic variant in our combined cohorts. Additionally, 4 out of 6 rtvFTD subjects had a strong family history for dementia. Conclusion: Our results demonstrate that rtvFTD, unlike svPPA, is not a pure sporadic, but a heterogeneous potential genetic variant of FTD, and screening for genetic causes for FTD should be performed in patients with rtvFTD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-201191

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patient selection.
Fig. 1 Patient selection.CC BY-NC · PubMed Central
Fig. 2 Pathological features of Case 3. Anterior cingulate cortex stained with phospho-tau (p-tau) monoclonal antibody (AT8: Pierce Biotechnology, Rockford, IL, USA). Extensive 3R and 4R tauopathy which is characteristic for MAPT related frontotemporal lobar degeneration is observed in neurons across all layers.
Fig. 2 Pathological features of Case 3. Anterior cingulate cortex stained with phospho-tau (p-tau) monoclonal antibody (AT8: Pierce Biotechnology, Rockford, IL, USA). Extensive 3R and 4R tauopathy which is characteristic for MAPT related frontotemporal lobar degeneration is observed in neurons across all layers.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

Metadata

Authors
Ulugut Erkoyun, H., van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., & Pijnenburg, Y.
Affiliations
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
  • Amsterdam Neuroscience (NL)
  • Genome diagnostics, Department of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands
  • Istanbul University (TR)
  • Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • Alzheimer Center Amsterdam, Department of Pathology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
  • Department of Clinical Genetics, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands
Venue
Journal of Alzheimer’s Disease
Published
2021-02-02
Volume
79
Issue
3
Pages
1195-1201
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W3119727308
Cited by
24
References
46
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 7
FWCI
3.41
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Funders
  • National Institute for Health and Care Research
  • University College London Hospitals NHS Foundation Trust
  • Alzheimer Nederland
  • Türk Nöroloji Derneği
  • Amsterdam Neuroscience
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
semantic dementia
MeSH terms
Progranulins, DNA-Binding Proteins, Female, Genetic Testing, Gyrus Cinguli, Humans, Functional Laterality, Male, Middle Aged, Genetic Variation, tau Proteins, Aphasia, Primary Progressive, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.